WebMD acquires medical news site JIM.fr to extend reach to French HCPs
Category: #health  | By Nikita Chaurasia  | Date: 2022-08-18 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

WebMD acquires medical news site JIM.fr to extend reach to French HCPs

Online medical news platform WebMD Health Corp. has reportedly announced the acquisition of French news platform JIM.fr, specializing in medical news, information, and education.

For the record, WebMD is the leading provider of health information to physicians as well as other healthcare professionals and consumers.

The takeover will bring together JIM.fr and WebMD’s flagship global brand, Medscape’s core competencies to healthcare professionals (HCPs).

Medscape, with its network of platforms, has a reach of more than 5 million physicians globally through health information, clinical news, and continuing medical education. With JIM.fr, Medscape will be able to strengthen its commitment to French and French-speaking HCPs.

Jeremy Schneider, Group General Manager, WebMD Global, said that Medscape’s current French edition and WebMD’s strong country-specific content are vital for the platform’s global commitment to French HCPs.

Jeremy added that with the acquisition, WebMD and JIM.fr will be to combine their assets and further enrich Medscape’s offerings to French and French-speaking professionals, and offer innovation to consumers.

Schneider further mentioned that Medscape and JIM.fr have the engagement and trust of several healthcare professionals in France.

JIM.fr is a leading medical news site in France, engaging with several thousands of HCPs, such as pharmacists, nurses, and physicians, across over 25 specializations.

Along with providing updates on the latest medical news and coverage of medical conferences and clinical science, the platform also offers an interactive and multidisciplinary education platform for the extensive healthcare team.

Dr. Gilles Haroche, Founder of JIM.fr, said that the platform, which sets itself apart from others in the sector with a humorous tone in its articles and giving original analyses of major issues in the medical world is happy to have its quality of work recognized by Medscape.

Post-completion of the transaction, the French platform will continue operations as an independent subsidiary of the American company, while the two will work on building and integrating their platforms, services, and products.

Source credit: https://www.prnewswire.com/news-releases/webmd-acquires-jimfr-expanding-reach-to-french-speaking-health-professionals-301608104.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Fintech firm PayPal to shed around 2000 staff as global economy plummets

Fintech firm PayPal to shed around 2000 staff as global economy plummets

By Nikita Chaurasia

PayPal, the U.S.-based fintech giant, has reportedly announced that it will cut nearly 2000 jobs, approximately 7% of its workforce, as it turns the latest prominent tech company to shed staff in a bid to cut costs. The online payments provider cl...

EasyJet sees a rise in bookings as customers plan their next vacations

EasyJet sees a rise in bookings as customers plan their next vacations

By Nikita Chaurasia

British multinational low-cost airline group, EasyJet, has reported a record surge in bookings for the month of January as people prioritized their travel plans for the coming year. The news comes as airlines world over start to show signs that they&...

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...